Orphanin FQ/nociceptin not only blocks but also reverses behavioral adaptive changes induced by repeated cocaine in

David Bebawy1, Paul Marquez, Seroje Samboul

  • 1Department of Pharmaceutical Sciences, College of Pharmacy, Western University of Health Sciences, Pomona, California, USA.

Biological Psychiatry
|April 3, 2010
PubMed
Abstract

Insights

Orphanin FQ/nociceptin (OFQ/N) blocks and reverses cocaine sensitization in mice. This peptide receptor ligand demonstrates potential in mitigating the harmful behavioral effects of repeated cocaine exposure.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Addiction Research

Background:

  • Orphanin FQ/nociceptin (OFQ/N) is the endogenous ligand for the opioid receptor-like (ORL1) receptor.
  • Previous studies indicated OFQ/N blocks cocaine sensitization in rats.
  • The current study investigates OFQ/N's effects on cocaine sensitization in mice.

Purpose of the Study:

  • To determine if OFQ/N blocks cocaine-induced motor and conditioned reward sensitization in mice.
  • To assess if OFQ/N can reverse established cocaine sensitization.
  • To evaluate OFQ/N's ability to prevent amplified sensitization after a secondary cocaine regimen.

Main Methods:

  • Wild-type and ORL1 knockout mice received OFQ/N or saline before cocaine or saline administration over multiple days.
  • Sensitization was assessed via locomotor activity and conditioned place preference tests.
  • Mice were subjected to single or repeated cocaine-sensitizing regimens with OFQ/N interventions.

Main Results:

  • OFQ/N significantly blocked cocaine-induced psychomotor sensitization in wild-type mice, but not in ORL1 knockout mice.
  • OFQ/N inhibited sensitization to cocaine's conditioned rewarding effects.
  • A preexisting locomotor sensitized response was reversed by OFQ/N treatment.
  • OFQ/N prevented the amplification of sensitization following a second cocaine-sensitizing regimen.

Conclusions:

  • OFQ/N effectively blocks the development of cocaine sensitization.
  • OFQ/N demonstrates the capacity to reverse established behavioral sensitization to cocaine.
  • These findings highlight OFQ/N's therapeutic potential in addressing maladaptive behaviors from repeated cocaine use.